Term
| suppress FSH and LH and prevent the follicle development |
|
Definition
|
|
Term
| suppress LH hormone release, thickens cervical mucus, creates atrophied endometrium; alters fallopian tube secretions and inhibit penetration of ovum by sperm |
|
Definition
|
|
Term
|
Definition
| mestranol, ethinyl estradiol, estradiol valerate |
|
|
Term
| converted to ethyinyl estradiol in liver; its potency is less than ethinyl estradiol |
|
Definition
|
|
Term
| most common in combined oral contraceptives |
|
Definition
|
|
Term
|
Definition
| medroxyprogesterone, megestrol acetate |
|
|
Term
| testosterone (nortestosterone) |
|
Definition
| binds ot progestin and androgen receptors; most BCP progestins |
|
|
Term
|
Definition
| anti-aldosterone action, anti-androgenic activity is similar to progesterone (Yaz, Yasmin) |
|
|
Term
| 1st generation progestins |
|
Definition
| norethindrone, norethynodrel |
|
|
Term
| considered gold standard,most common progestine; ortho-novum, norinyl, ovcon |
|
Definition
|
|
Term
| no androgenic activity, not currently on US market |
|
Definition
|
|
Term
| 3rd generation progestins |
|
Definition
| norgestrel, levonorgestrel |
|
|
Term
|
Definition
| desogestrel, norgestimate |
|
|
Term
| can cause potassium retention, not likely to cause cyclic water retention (diuretic effect) |
|
Definition
|
|
Term
| side effects to too much include nausea, increased breast size, thromboembolic complications, HTN, decreased libido, increased cholesterol in bile |
|
Definition
|
|
Term
| side effects from too much include acne, depression, fatigue |
|
Definition
|
|
Term
| side effects from a deficiency: atrophic vaginitis, continuous bleeding, early or mid-cycle spotting, hypomenorrhea, vasomotor symptoms |
|
Definition
|
|
Term
| side effects from a deficiency include dysmenorrhea, hypermenorrhea, late cycle spotting |
|
Definition
|
|
Term
| side effects from deficiency include depression, fatigue, tiredness, acne, oily skin, increased LDL levels, decreased HDL levels, Diabetogen effect |
|
Definition
|
|
Term
| SEs include breast tenderness, headaches, hypertension, cyclic weight gain secondary to fluid retention |
|
Definition
|
|
Term
| causes increased OC efficacy |
|
Definition
| ascorbic acid, APAP, atorvastatin, Rosuvastatin; NNRTIs, Protease inhibitors |
|
|
Term
|
Definition
| anticonvulsants, ABX, Rifampin, Theophyllin, St. John's Wort, Sulfonamides, Griseofulvin |
|
|
Term
| OCs increased the effectiveness of these |
|
Definition
| xanyx, Librium, diazepam, theophylline/caffeine, cyclosporine, corticosteroids, alcohol, BB, TCA, Ropinirole, Zolmitriptan |
|
|
Term
| OCs decreased the effectiveness of these |
|
Definition
| Temazepam, Warfarin, THyroid agents, hypoglycemic , methyldopa, metformin, amprenavir |
|
|
Term
| flexible inplant inserted into skin of inner upper arm, Etonorgestrel progestin |
|
Definition
|
|
